france Mentré

INSERM

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (8)

Andrew Hooker

Professor of Pharmacometrics

Uppsala University

SWEDEN

View details

Yevgen Ryeznik

Senior Lecturer/Associate Professor

Uppsala University

SWEDEN

View details

Weng Kee Wong

Professor

UCLA

UNITED STATES

View details

Jérémie Guedj

Université Paris Cité

FRANCE

View details

Cédric LAOUENAN

Associate professor

Université Paris-Saclay

FRANCE

View details

Ralf-Dieter Hilgers

RWTH Aachen University

GERMANY

View details

Matthis Synofzik

Professor

Hertie Institute for clinical brain research

GERMANY

View details

Peter Horby

Professor of Emerging Infectious Diseases

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

france Mentré

Research Interests

Explore related searches

Contact this professor

Articles (10)

Viral Dynamic Models During COVID‐19: Are We Ready for the Next Pandemic?

A Pharmacometrics‐Informed Trial Simulation Framework for Optimizing Study Designs for Disease‐Modifying Treatments in Rare Neurological Disorders

Impact of covariate model building methods on their clinical relevance evaluation in population pharmacokinetic analyses: comparison of the full model, stepwise covariate model (SCM) and SCM+ approaches - further results based on more conventional practices

Design optimization of longitudinal studies using metaheuristics: Application to lithium pharmacokinetics

Using Fisher Information Matrix to predict uncertainty in covariate effects and power to detect their relevance in Non-Linear Mixed Effect Models in pharmacometrics

Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC)

Longitudinal Analysis of Natural History Progression of Rare and Ultra‐Rare Cerebellar Ataxias Using Item Response Theory

Impact of covariate model building methods on their clinical relevance evaluation in population pharmacokinetic analyses: comparison of the full model, stepwise covariate model (SCM) and SCM+ approaches

Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial

Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies

Collaborators (8)

Andrew Hooker

Yevgen Ryeznik

Weng Kee Wong

Jérémie Guedj

Cédric LAOUENAN

Ralf-Dieter Hilgers

Matthis Synofzik

Peter Horby

Make your next move.